Archive – This webinar was presented by CISCRP on October 10, 2018.
Our lives are impacted by clinical research every day. Each medication you take was proven safe and made available with the help of clinical research and the individuals who participated. But what exactly are clinical research studies? What are the safeguards in place to protect those who participate? What are the risks and benefits to evaluate whether participating is the right choice for you?
On Wednesday, October 10 we hosted a free webinar that will feature an overview presentation about the clinical research process and a panel discussion with research professionals and study volunteers. This webinar was postponed from its original intended date this past Spring.
Archive Version – this webinar was originally presented on June 15, 2017.
Informed consent is an ethical, mandatory, and fundamental principle of healthcare research. It respects the clinical trial volunteer’s authority to decide whether to participate, reviews their role and responsibilities, and highlights the risks involved. Unfortunately, 18 to 30% of patients enrolling in a trial drop out, with 13% of drop-outs due to patient misunderstanding of consent expectations or related issues.
FDA guidance and patient advocacy groups are driving adoption of electronic consent (eConsent) to make the consenting process more engaging and easier to understand for patients and caregivers. With patient recruitment costs accounting for nearly 1/3 of the total trial cost, there is a financial as well as an ethical reason to make sure patients fully understand the clinical trial process and their vital role. This webinar will review the current informed consent process and how eConsent may help to improve patient comprehension, engagement, and retention.
The presenter from CISCRP will discuss:
- The purpose of informed consent
- Current rules and regulations around the informed consent process
- Data and insights on the number of patients who drop out of studies due to lack of understanding the informed consent
The presenter from DrugDev will discuss how eConsent:
- Ensures patient understanding through multimedia education
- Improves patient retention and reduces recruitment needs
- Provides insight and metrics into how patients read and understand documents
- Improves regulatory compliance
Founder and Board Chair at CISCRP
President of DrugDev Patient Solutions
Archive Version – listen to our free archived webinar to discuss how a growing number of sponsors, contract research organizations (CROs), and research centers are turning to Patient Advisory Board panels to solicit patient feedback on various clinical research-related areas – including the improvement of protocol design, study feasibility, recruitment and retention, and collecting a deeper understanding of patient perceptions and receptivity to current approaches, new practices, and technology solutions.
For several years, CISCRP has been organizing and facilitating patient advisory board panels with great success. CISCRP has a team in place to assist with all aspects of patient advisory board activity including board strategy development and planning; board member selection and engagement; board venue identification and development; discussion guide and board materials development; meeting(s) coordination and facilitation; and analysis, compilation, and dissemination of board suggestions and insights.
As an independent non-profit organization, CISCRP is uniquely positioned to assist companies and institutions in organizing and running their patient advisory board panels. CISCRP’s extensive relationships with patient advocacy groups, patient communities, and former study volunteers play a key role in ensuring the best board composition.
This webinar demonstrates how Patient Advisory Board panels are a vital approach to engaging study volunteers and enhancing their participation experience, and how CISCRP can work with your organization to facilitate a successful patient advisory board strategy.
Ken Getz is the Founder and Board Chair at CISCRP, as well as an associate professor at the Center for the Study of Drug Development, Tufts University School of Medicine where he studies R&D management and operating models, investigative site, outsourcing, and study volunteer trends and policies. A well-known speaker at conferences, symposia, universities, and corporations, Ken has published more than 200 articles and chapters in peer-review journals, books, and in the trade press.
Annick Anderson is the Director of Research Services at CISCRP. Annick oversees the implementation, management and data analysis of various research projects – including the CISCRP Patient Advisory Board panels. Annick has more than 15 years market research experience in the healthcare, life sciences, and consumer goods industries. She has conducted numerous primary and secondary research projects among clinical research professionals and patients.